These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17576439)

  • 1. Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.
    Williams LJ; Guernsey DL; Casson AG
    Curr Oncol; 2006 Feb; 13(1):33-43. PubMed ID: 17576439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and molecular biology of Barrett esophagus.
    Casson AG; Williams L; Guernsey DL
    Semin Thorac Cardiovasc Surg; 2005; 17(4):284-91. PubMed ID: 16428034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies in Barrett esophagus.
    Dunbar KB; Spechler SJ
    Mayo Clin Proc; 2014 Jul; 89(7):973-84. PubMed ID: 24867396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrett esophagus.
    Slehria S; Sharma P
    Curr Opin Gastroenterol; 2003 Jul; 19(4):387-93. PubMed ID: 15703582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region.
    Wu TT; Watanabe T; Heitmiller R; Zahurak M; Forastiere AA; Hamilton SR
    Am J Pathol; 1998 Jul; 153(1):287-94. PubMed ID: 9665490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroesophageal reflux and cancer.
    Turcotte S; Duranceau A
    Thorac Surg Clin; 2005 Aug; 15(3):341-52. PubMed ID: 16104125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett esophagus and risk of esophageal cancer: a clinical review.
    Spechler SJ
    JAMA; 2013 Aug; 310(6):627-36. PubMed ID: 23942681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Pathologic Assessment of Gastroesophageal Reflux Disease: The Squamo-Oxyntic Gap.
    Chandrasoma P; DeMeester T
    Adv Exp Med Biol; 2016; 908():41-78. PubMed ID: 27573767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular biology of esophageal adenocarcinoma.
    Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
    J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
    Feith M; Stein HJ; Mueller J; Siewert JR
    Dis Esophagus; 2004; 17(4):322-7. PubMed ID: 15569371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
    Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
    Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus.
    Sarbia M; Arjumand J; Wolter M; Reifenberger G; Heep H; Gabbert HE
    Am J Clin Pathol; 2001 Jun; 115(6):835-40. PubMed ID: 11392879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical and histopathologic focus on Barrett esophagus and Barrett-related dysplasia.
    Voltaggio L; Montgomery EA; Lam-Himlin D
    Arch Pathol Lab Med; 2011 Oct; 135(10):1249-60. PubMed ID: 21970480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
    Abraham SC; Wang H; Wang KK; Wu TT
    Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
    Vaughan TL; Kristal AR; Blount PL; Levine DS; Galipeau PC; Prevo LJ; Sanchez CA; Rabinovitch PS; Reid BJ
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):745-52. PubMed ID: 12163328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.